SMCY uses a synthetic long with call sales, capturing limited gains and nearly the full downside of SMCI, underperforming in any market. See why SMCY ETF is a sell.
For this month’s edition of 5 Interesting Startup Deals, all the funded companies that caught our eye were hardware-centric, from a medical device for at-home acne treatment, to an artificial retina ...
Follow Live Coverage on PhysicsWallah IPO GMP, Subscription Status, Grey Market Premium, Listing Date, Review and More ...
EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three ...
2d
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...
The shift toward earlier shopping also reflects economic caution. According to Deloitte’s 2025 Holiday Retail Forecast, total ...
Netanyahu gearing up walk-back from pledge not to grant safe passage to holed-up Hamas fighters * France raises concern with ...
Wondering if Hims & Hers Health is a hidden value gem or already fairly priced? You're not alone, as plenty of investors are sizing up its potential in today's dynamic market. The stock is no stranger ...
The S&P/ASX 200 is set to rise after major US benchmarks posted an encouraging reversal overnight. Here are today's top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback